Brief: Movano Health Submits Response To FDA As Part Of Final Review Phase For EvieMED
Nov 4 (Reuters) - Movano Inc MOVE.O :
* MOVANO HEALTH SUBMITS RESPONSE TO FDA AS PART OF FINAL
REVIEW
PHASE FOR EVIEMED
* MOVANO INC - HEALTH OPTIMISTIC ON EVIEMED'S 510(K)
CLEARANCE
Source text: ID:nPn6P4t1ja
Further company coverage: MOVE.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Corvex
See all newsBrief: Corvex Enters Up To $250 Million At-The-Market Stock Offering Agreement with Chardan Capital Markets
RCS - Corvex Management - Corvex requests vote on Whitbread board seat
U.S. STOCKS ON THE MOVE-RBB Bancorp, Roblox, Open Lending
U.S. STOCKS ON THE MOVE-Amkor Technology, Dynatrace, Corvex
Corvex rises after naming ex‑Morgan Stanley banker Moreland as CFO